1,211
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Silencing of let-7b-5p inhibits ovarian cancer cell proliferation and stemness characteristics by Asp-Glu-Ala-Asp-box helicase 19A

, , , , ORCID Icon, & show all
Pages 7666-7677 | Received 10 Aug 2021, Accepted 14 Sep 2021, Published online: 06 Oct 2021

References

  • Jayson GC, Kohn EC, Kitchener HC, et al. Ovarian cancer. Lancet. 2014 Oct 11;384(9951):1376–1388.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020 Jan;70(1):7–30.
  • Ricciardelli C, Oehler MK. Diverse molecular pathways in ovarian cancer and their clinical significance. Maturitas. 2009 Mar 20;62(3):270–275.
  • Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018 Jul;68(4):284–296.
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209–249.
  • Muñoz-Galván S, Carnero A. Targeting cancer stem cells to overcome therapy resistance in ovarian cancer. Cells. 2020 Jun 4;9(6):1402.
  • Keyvani V, Farshchian M, Esmaeili SA, et al. Ovarian cancer stem cells and targeted therapy. J Ovarian Res. 2019 Dec 6;12(1):120.
  • Mihanfar A, Aghazadeh Attari J, Mohebbi I, et al. Ovarian cancer stem cell: a potential therapeutic target for overcoming multidrug resistance. J Cell Physiol. 2019 Apr;234(4):3238–3253.
  • Li SS, Ma J, Wong AST. Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism. J Gynecol Oncol. 2018 Mar;29(2):e32.
  • Qin Z, He W, Tang J, et al. MicroRNAs provide feedback regulation of epithelial-mesenchymal transition induced by growth factors. J Cell Physiol. 2016 Jan;231(1):120–129.
  • Kafshdooz L, Pourfathi H, Akbarzadeh A, et al. The role of microRNAs and nanoparticles in ovarian cancer: a review. Artif Cells Nanomed Biotechnol. 2018;46(sup2):241–247.
  • Cheng L, Wu S, Zhang K, et al. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies. J Ovarian Res. 2017 Nov 3;10(1):73.
  • Yang B, Sun L, Liang L. MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ. J Ovarian Res. 2019 Oct 22;12(1):100.
  • Rong J, Xu L, Hu Y, et al. Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer. Cancer Cell Int. 2020;20(1):470.
  • Rong J, Xu L, Hu Y, et al. Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer. Cancer Cell Int. 2020;20(1):470.
  • Gao Y, Ma H, Hou D. Sevoflurane represses proliferation and migration of glioma cells by regulating the ANRIL/let-7b-5p axis. Cancer Biother Radiopharm. 2020 Aug 19. DOI:10.1089/cbr.2020.3596
  • Li S, Peng F, Ning Y, et al. SNHG16 as the miRNA let-7b-5p sponge facilitates the G2/M and epithelial-mesenchymal transition by regulating CDC25B and HMGA2 expression in hepatocellular carcinoma. J Cell Biochem. 2020 Mar;121(3):2543–2558.
  • Liu J, Yoo J, Ho JY, et al. Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer. J Ovarian Res. 2021 Apr 28;14(1):59.
  • Kuang Y, Xu H, Lu F, et al. Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer. Cancer Sci. 2021 Jan;112(1):231–242.
  • Zhang Y, Jia LG, Wang P, et al. The expression and significance of lncRNA HOST2 and microRNA let-7b in HPV-positive cervical cancer tissues and cell lines. Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2380–2390.
  • Gao Y, Meng H, Liu S, et al. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet. 2015 Feb 1;24(3):841–852.
  • Delalande A, Postema M, Mignet N, et al. Ultrasound and microbubble-assisted gene delivery: recent advances and ongoing challenges. Ther Deliv. 2012 Oct;3(10):1199–1215.
  • Suzuki R, Oda Y, Utoguchi N, et al. Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles. J Control Release. 2011 Jan 5;149(1):36–41.
  • Espitalier F, Darrouzain F, Escoffre JM, et al. Enhanced amikacin diffusion with ultrasound and microbubbles in a mechanically ventilated condensed lung rabbit model. Front Pharmacol. 2019;10:1562.
  • Wang DS, Panje C, Pysz MA, et al. Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. Radiology. 2012 Sep;264(3):721–732.
  • Kopechek JA, McTiernan CF, Chen X, et al. Ultrasound and microbubble-targeted delivery of a microRNA inhibitor to the heart suppresses cardiac hypertrophy and preserves cardiac function. Theranostics. 2019;9(23):7088–7098.
  • Wang J, Li Y, Ma Q, et al. miR‑378 in combination with ultrasonic irradiation and SonoVue microbubbles transfection inhibits hepatoma cell growth. Mol Med Rep. 2020 Jun;21(6):2493–2501.
  • Wu J, Sun L, Liu T, et al. Ultrasound-targeted microbubble destruction-mediated downregulation of EZH2 inhibits stemness and epithelial-mesenchymal transition of liver cancer stem cells. Onco Targets Ther. 2021;14:221–237.
  • Yang C, Li B, Yu J, et al. Ultrasound microbubbles mediated miR-let-7b delivery into CD133(+) ovarian cancer stem cells. Biosci Rep. 2018 Oct 31;38(5):5.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001 Dec;25(4):402–408.
  • Torre LA, Islami F, Siegel RL, et al. Global cancer in women: burden and trends. Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444–457.
  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016 Mar-Apr;66(2):115–132.
  • Foster R, Buckanovich RJ, Rueda BR. Ovarian cancer stem cells: working towards the root of stemness. Cancer Lett. 2013 Sep 10;338(1):147–157.
  • Deb B, Uddin A, Chakraborty S. miRNAs and ovarian cancer: An overview. J Cell Physiol. 2018 May;233(5):3846–3854.
  • Lu X, Li G, Liu S, et al. MiR-585-3p suppresses tumor proliferation and migration by directly targeting CAPN9 in high grade serous ovarian cancer. J Ovarian Res. 2021 Jul 8;14(1):90.
  • Zhang S, Liu J, He J, et al. MicroRNA‑193a‑5p exerts a tumor suppressive role in epithelial ovarian cancer by modulating RBBP6. Mol Med Rep. 2021 Aug;24(2). doi:10.3892/mmr.2021.12221
  • Xiao X, Zhang Y, Lin Q, et al. The better effects of microbubble ultrasound transfection of miR-940 on cell proliferation inhibition and apoptosis promotion in human cervical cancer cells. Onco Targets Ther. 2019;12:6813–6824.
  • Staicu CE, Predescu DV, Rusu CM, et al. Role of microRNAs as clinical cancer biomarkers for ovarian cancer: a short overview. Cells. 2020 Jan 9;9(1):169.
  • Linder P, Jankowsky E. From unwinding to clamping - the DEAD box RNA helicase family. Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):505–516.
  • Jiang Y, Wang B, Li Y, et al. DDX19A promotes metastasis of cervical squamous cell carcinoma by inducing NOX1-mediated ROS production. Front Oncol. 2021;11:629974.
  • Cava C, Bertoli G, Ripamonti M, et al. Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition. PLoS One. 2014;9(5):e97681.
  • Yu T, Luo L, Wang L. Ultrasound as a cancer chemotherapy sensitizer: the gap between laboratory and bedside. Expert Opin Drug Deliv. 2016;13(1):37–47.
  • Liu Q, Zhong X, Zhang Y, et al. Ultrasound enhances ZD2767P-carboxypeptidase G2 against chemoresistant ovarian cancer cells by altering the intracellular pharmacokinetics of ZD2767D. Mol Pharm. 2020 Jun 1;17(6):1922–1932.